Angiotech starts Phase II RA trial

Angiotech (ANPI; TSE:ANP) began an open-label Phase II trial of its Paxceed micellar paclitaxel injection to treat 50 rheumatoid arthritis (RA) patients not responding to at least one disease-modifyin...